title: Challenging the soaring price of cancer medicines: a call for equity and transparency.
authors.affiliation: Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Cancer Research Center of Marseille, Institut Paoli-Calmettes, INSERM U1068, CNRS 7258, Aix-Marseille Université, Marseille Aix-Marseille University, Marseille goncalvesa@ipc.unicancer.fr.
authors.forename: A
authors.initials: A
authors.lastname: Gonçalves
authors.affiliation: Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Cancer Research Center of Marseille, Institut Paoli-Calmettes, INSERM U1068, CNRS 7258, Aix-Marseille Université, Marseille Aix-Marseille University, Marseille.
authors.forename: D
authors.initials: D
authors.lastname: Maraninchi
authors.affiliation: Department of Clinical Haematology, Hôpital Pitié-Salpêtrière, Paris Pierre et Marie Curie University, Paris, France.
authors.forename: J-P
authors.initials: JP
authors.lastname: Vernant
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs / Q000331:legislation & jurisprudence / Q000639:trends*; D000069576:Health Equity / Q000191:economics* / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics*; D012106:Research / Q000191:economics / Q000639:trends
chemical_list: D000970:Antineoplastic Agents